New dengue vaccine could worsen disease in some people

November 30, 2017
New dengue vaccine could worsen disease in some people
In this Friday, Feb. 5, 2016 file photo, Nadia Gonzalez, enclosed in a mosquito net, recovers from a bout of dengue fever at a hospital in Luque, Paraguay. Drugmaker Sanofi said Thursday, Nov. 30, 2017, that its dengue vaccine—the world's first—could put people at risk of severe disease if they haven't previously been infected, according to new long-term data. (AP Photo/Jorge Saenz, File)

Drugmaker Sanofi says that its dengue vaccine, the world's first, should only be given to people who have previously been sickened by the virus, according to new long-term data.

In a statement, Sanofi said it had recently examined six years of patient data. Scientists concluded that while the vaccine protects people against further infection if they've already been infected with , that's not the case for people who haven't previously been sickened by the disease.

"For those not previously infected by dengue virus...the analysis found that in the longer term, more cases of severe disease could occur following vaccination," Sanofi said. "These findings highlight the complex nature of dengue infection."

People who catch dengue more than once can be at risk of a hemorrhagic version of the disease. The mosquito-spread disease is found in tropical and sub-tropical climates worldwide. It causes a flu-like disease that can cause joint pain, nausea, vomiting and a rash. In severe cases, dengue can cause breathing problems, hemorrhaging and organ failure.

The World Health Organization says that about half the world's population is at risk of dengue and estimates that about 96 million people are sickened by the viral infection every year.

Sanofi is proposing that national authorities update their prescribing information. It also said doctors should assess the likelihood of prior in people before choosing whether they should get the vaccine.

"For individuals who have not been previously infected by , vaccination should not be recommended," Sanofi said. The vaccine is currently recommended in most dengue-endemic countries for people over age nine.

The company expects to take a 100 million euro ($118 million) loss based on the news.

There is no specific treatment for dengue and there are no other licensed vaccines on the market.

Explore further: Focus on dengue vision problems

Related Stories

Focus on dengue vision problems

September 8, 2017
The first insights into dengue virus damage to the eye start the work needed to combat one of the important side effects in the infectious disease's spread across the world.

First dengue vaccine goes on sale in Guatemala

November 22, 2016
The world's first vaccine against dengue, a mosquito-borne virus that causes fever and pain and can be fatal, will go on sale in Guatemala within weeks, the French company making it said Tuesday.

8 in 10 Indonesian children has been infected with dengue

June 16, 2017
Indonesia has one of the highest burdens of dengue fever, a mosquito-borne virus, in the world, and children account for many cases. Well over half of all children in urban areas are infected with dengue by the age of 5, ...

Data analyses back Sanofi dengue vaccine: study

July 28, 2015
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.

New evidence shows second dengue infection can be more severe due to antibody levels

November 3, 2017
(Medical Xpress)—A team of researchers from the U.S. and Nicaragua has found evidence that suggests people infected a second time by the dengue virus may experience a more severe form of dengue fever if their antibody levels ...

Philippine FDA orders Sanofi to take down dengue vaccine ads

January 3, 2017
The Philippine Food and Drug Administration said Tuesday that it has ordered pharmaceutical giant Sanofi Pasteur Inc. to stop airing television and radio advertisements for its dengue vaccine in violation of a ban on promoting ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.